Aethlon Medical, Inc.
AEMD
$1.76
-$0.21-10.66%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.81M | 2.90M | 2.62M | 2.50M | 2.69M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.81M | 2.90M | 2.62M | 2.50M | 2.69M |
| Operating Income | -1.81M | -2.90M | -2.62M | -2.50M | -2.69M |
| Income Before Tax | -1.75M | -2.81M | -2.57M | -2.43M | -3.47M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.75M | -2.81M | -2.57M | -2.43M | -3.47M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.75M | -2.81M | -2.57M | -2.43M | -3.47M |
| EBIT | -1.81M | -2.90M | -2.62M | -2.50M | -2.69M |
| EBITDA | -1.73M | -2.82M | -2.53M | -2.41M | -2.60M |
| EPS Basic | -1.01 | -1.61 | -2.76 | -7.41 | -11.02 |
| Normalized Basic EPS | -0.63 | -1.01 | -1.72 | -4.65 | -5.15 |
| EPS Diluted | -1.01 | -1.61 | -2.76 | -7.41 | -11.02 |
| Normalized Diluted EPS | -0.63 | -1.01 | -1.72 | -4.65 | -5.15 |
| Average Basic Shares Outstanding | 1.75M | 1.74M | 932.20K | 327.40K | 314.60K |
| Average Diluted Shares Outstanding | 1.75M | 1.74M | 932.20K | 327.40K | 314.60K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |